It enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system effects
These results are impressive given the degree of sustained weight reduction and decrease in risk of diabetes, Ania Jastreboff, MD, PhD, director of the Yale Obesity Research Center, said in a statement from Lilly
What the Human Trial Record Shows This compound has a documented history in human clinical research that distinguishes it from the vast majority of synthetic research peptides, which have never been tested in human subjects
Previous work had already uncovered a cardiovascular benefit in people with type 2 diabetes
Niektrzy producenci stosuj specjalne technologie enkapsulacji, ktre maj chroni peptyd przed degradacj i poprawia jego wchanianie
Freezing can damage the peptide's molecular structure, rendering the medication ineffective or unstable for injection